1. Home
  2. FTS vs IQV Comparison

FTS vs IQV Comparison

Compare FTS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortis Inc.

FTS

Fortis Inc.

HOLD

Current Price

$54.81

Market Cap

29.0B

Sector

Utilities

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$170.35

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTS
IQV
Founded
1885
1982
Country
Canada
United States
Employees
9900
93000
Industry
Electric Utilities: Central
Biotechnology: Commercial Physical & Biological Resarch
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.0B
28.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
FTS
IQV
Price
$54.81
$170.35
Analyst Decision
Buy
Strong Buy
Analyst Count
2
16
Target Price
$67.00
$227.13
AVG Volume (30 Days)
490.0K
1.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
3.22%
N/A
EPS Growth
N/A
4.67
EPS
N/A
1.61
Revenue
N/A
$9,739,000,000.00
Revenue This Year
$11.05
$6.77
Revenue Next Year
$5.32
$5.89
P/E Ratio
$22.72
$106.17
Revenue Growth
N/A
41.60
52 Week Low
$46.46
$134.65
52 Week High
$58.78
$247.05

Technical Indicators

Market Signals
Indicator
FTS
IQV
Relative Strength Index (RSI) 35.44 51.09
Support Level $50.26 $159.08
Resistance Level $57.84 $172.80
Average True Range (ATR) 0.73 6.75
MACD -0.14 0.68
Stochastic Oscillator 1.92 60.50

Price Performance

Historical Comparison
FTS
IQV

About FTS Fortis Inc.

Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving 3.5 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: